Steve DeBroux
Steve is at Seattle Genetics, a global biotechnology company that discovers, develops and commercializes transformative medicines targeting cancer. He currently works with the pharmacovigilance (patient safety) team as a senior BI analyst, providing adverse event data reporting in support of signal evaluation, risk management, and regulatory submissions.
Program-Alumni
MSIM First name
Steve Last name
DeBroux Graduation year
2013 URL
http://www.stevedebroux.com/